Printer Friendly

COMPANY INFORMATION
Ondine Biopharma Corporation 910-1100 Melville St Vancouver, BC V6E 4A6 Tel: (604) 669-0555 Fax: (604) 669-0533 Contact Name Carolyn Cross Industry Pharmaceuticals		Key Executives Carolyn Cross, CEO William S. Harper, CFO Develops and markets broad-spectrum anti-infectives as an alternative to antibiotics using photodisinfection (PDD), which combines the use of a light source and photosensitizing agent to treat bacterial, fungal and viral infections.
FP ADVISOR COVERAGE Ondine Biopharma Corporation • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/OBP $0.05 $0.17 $0.02 n.a. n.a. n.a. 1.4 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 51,004 n.a. $-0.08 Sept. 30/09 -54.55% -69.66% -54.63% $4,661
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 912 1,605 1,619 Net income (10,270) (13,158) (11,963) Total assets 2,946 13,004 18,464 $ $ $ Earnings per share* (0.17) (0.24) (0.25) % % % Return on equity (168.62) (95.92) (72.29)   * Common
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 845 738 Net income (5,492) (10,879) $ $ Earnings per share (0.08) (0.18)

COMPANY NEWS

Results for 'Ondine Biopharma Corporation' from past 30 days: No hits. (Links are to articles.)